AU2015904350A0 - Composition and methods for the prevention and treatment of muscle atrophy - Google Patents

Composition and methods for the prevention and treatment of muscle atrophy

Info

Publication number
AU2015904350A0
AU2015904350A0 AU2015904350A AU2015904350A AU2015904350A0 AU 2015904350 A0 AU2015904350 A0 AU 2015904350A0 AU 2015904350 A AU2015904350 A AU 2015904350A AU 2015904350 A AU2015904350 A AU 2015904350A AU 2015904350 A0 AU2015904350 A0 AU 2015904350A0
Authority
AU
Australia
Prior art keywords
prevention
treatment
composition
methods
muscle atrophy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015904350A
Inventor
Peter M. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Peter M Dr
Original Assignee
Smith Peter M Dr
Filing date
Publication date
Application filed by Smith Peter M Dr filed Critical Smith Peter M Dr
Publication of AU2015904350A0 publication Critical patent/AU2015904350A0/en
Abandoned legal-status Critical Current

Links

AU2015904350A 2015-10-23 Composition and methods for the prevention and treatment of muscle atrophy Abandoned AU2015904350A0 (en)

Publications (1)

Publication Number Publication Date
AU2015904350A0 true AU2015904350A0 (en) 2015-11-05

Family

ID=

Similar Documents

Publication Publication Date Title
EP3347469A4 (en) Methods and compositions for the treatment of glaucoma
EP3634424A4 (en) Compositions and methods for preventing or treating muscle conditions
AU2018297285A1 (en) Compositions and methods for treating or preventing endocrine FGF-linked diseases
EP3408344A4 (en) Well treatment methods and compositions
EP3602606A4 (en) Surface treatment methods and compositions therefor
EP3341392A4 (en) Compositions and methods for treatment of pain
EP3576776A4 (en) Compositions and methods for treating heart failure
EP3294761A4 (en) Compositions and methods for treatment and prevention of uropathogenice. coli
EP3538189A4 (en) Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
EP3558279A4 (en) Compositions and methods for the treatment of chronic pain
HK1249515A1 (en) Methods and compositions for the prevention and treatment of hearing loss
EP3720421A4 (en) Compositions and methods for the treatment of metabolic conditions
EP3454901A4 (en) Compositions and methods for treating spinal muscular atrophy
EP3253211A4 (en) Compositions and methods for treatment of edema
EP3368048A4 (en) Methods and compositions for the treatment of amyloidosis
EP3429584A4 (en) Compositions and methods for the treatment of presbyopia
EP3373922A4 (en) Compositions and methods for treatment of homocystinuria
EP3341006A4 (en) Compositions and methods for the treatment of neurodamage
EP3349719A4 (en) Compositions and methods for the treatment and prevention of radiation dermatitis
ZA201900984B (en) Methods and compositions for the treatment of warts
HK1255695A1 (en) Composition and methods for the treatment of blepharoptosis
PL3283064T3 (en) Derivatives used in the treatment of muscle atrophy
EP3600291A4 (en) Compositions and methods for treating synucleinopathies
EP3568020A4 (en) Compositions and methods for the treatment of demyelinating conditions